The ULISSE registry has demonstrated the real-world performance of the Ultimaster biodegradable polymer sirolimus-eluting stent (BP-SES) in a large cohort of patients undergoing percutaneous coronary intervention, including a large proportion of patients presenting with acute myocardial infarction (AMI).

One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry

Ferrante, Giuseppe;Chiarito, Mauro;Colombo, Antonio;
2019

Abstract

The ULISSE registry has demonstrated the real-world performance of the Ultimaster biodegradable polymer sirolimus-eluting stent (BP-SES) in a large cohort of patients undergoing percutaneous coronary intervention, including a large proportion of patients presenting with acute myocardial infarction (AMI).
acute myocardial infarction
biodegradable-polymer sirolimus-eluting coronary stent
percutaneous coronary interventions
stent thrombosis
Aged
Cardiovascular Agents
Coronary Artery Disease
Coronary Thrombosis
Female
Humans
Italy
Male
Middle Aged
Myocardial Infarction
Percutaneous Coronary Intervention
Polymers
Progression-Free Survival
Prosthesis Design
Recurrence
Registries
Retrospective Studies
Risk Factors
Sirolimus
Time Factors
Absorbable Implants
Drug-Eluting Stents
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/69711
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact